Rehmann Capital Advisory Group’s NxStage Medical Inc. NXTM Stock Holding History

Rehmann Capital Advisory Group’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-200	Closed	-$5.72K	–	2179
2018 Q4	$5.72K	Hold	200	–	–	﹤0.01%	1216
2018 Q3	$5.58K	Hold	200	–	–	﹤0.01%	1536
2018 Q2	$5.58K	Hold	200	–	–	﹤0.01%	1513
2018 Q1	$5K	Buy	+200	New	+$4.87K	﹤0.01%	1544

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Rehmann Capital Advisory Group's NXTM Position: Q1 2019 in Review

Rehmann Capital Advisory Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 200 shares — an estimated $5.72K sold.

Rehmann Capital Advisory Group first reported a position in NXTM in Q1 2018 and held it in 4 quarters. The position peaked at $5.72K in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Rehmann Capital Advisory Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Rehmann Capital Advisory Group sold 200 NxStage Medical Inc. shares in Q1 2019, an estimated $5.72K.
Rehmann Capital Advisory Group first reported a position in NxStage Medical Inc. in Q1 2018 and held it in 4 quarters.
Rehmann Capital Advisory Group's NxStage Medical Inc. position peaked at $5.72K in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2019, filed 22 May 2019.